Welcome to our dedicated page for JUPW news (Ticker: jupw), a resource for investors and traders seeking the latest updates and insights on JUPW stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect JUPW's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of JUPW's position in the market.
Jupiter Wellness, Inc. (NASDAQ:JUPW) has signed an exclusive distribution agreement for Safe Sea products in Florida, effective through 2021. Safe Sea is known for its sunscreen that protects against jellyfish stings and sea lice, along with providing UVA/UVB protection. CEO Brian John emphasized that this partnership aligns with their mission of high-quality skin care and may lead to future collaborations. The deal utilizes their existing sun care distribution network, enhancing their market position.
Jupiter Wellness, Inc. (NASDAQ:JUPW) announced the successful closing of its initial public offering (IPO) comprising 933,333 units with gross proceeds of $7 million. Each unit includes one share of common stock and one warrant. The offering saw Aegis Capital exercise its option to purchase an additional 140,000 warrants. The shares and warrants began trading on October 30, 2020, under the symbols JUPW and JUPWW. The registration statement was declared effective by the SEC on the same date. Prospectus copies are available through the SEC or Aegis Capital.